Clinical Research Studies Support Economic Growth and Development During A Pandemic, While Making a Global Difference Springfield, Missouri; November 12, 2020 – QPS announced…
QPS is a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since 1995. An award-winning leader focused…
QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative…
QPS, a global contract research organization (CRO) that provides GLP-compliant discovery, preclinical, and clinical drug development services, announced a newly developed capability to conduct…
As drug companies race to find treatments and vaccines to combat the novel coronavirus, QPS, a global contract research organization (CRO) providing discovery, preclinical…
Since September 19, 2016, QPS has closely collaborated with G-CURE, a cardiovascular research organization originating from and closely linked to the Department of Cardiology at…
Newark, Delaware, September 18, 2019 – QPS, a leading contract research organization (CRO), continues to expand its global footprint with new clinics in the Netherlands and…
Newark, Delaware, June 18, 2019 – QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced continuing…
Newark, Delaware, May 20, 2019 – QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, has been awarded…
NEWARK, Del., May 20, 2019 /PRNewswire/ — QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced…